Michael T. Redman

Michael T. Redman

Vorstandsvorsitzender bei
Theratome Bio, Inc.
71 Jahre
Health Technology
Commercial Services
Consumer Services

Profil

Michael T.
Redman
was the founder of Opexa Pharmaceuticals, Inc. (2001) as Chief Executive Officer and Oncolix, Inc. (2006) as Chief Executive Officer & Director.
Mr. Redman is currently the Chief Executive Officer at Theratome Bio, Inc. Former positions include President, Chief Executive Officer, CFO & Director at Advanced Environmental Petroleum Producers, Inc., Chief Executive Officer at Botanix Pharmaceuticals Ltd., Director at Oncolix, Inc. (2006-2019), Principal at Wyeth LLC, Principal at Aronex Pharmaceuticals, Inc., Principal at Repros Therapeutics, Inc., Chief Operating Officer & Executive Vice President at Genprex, Inc. (2019-2021), and Principal at Biovail Pharmaceuticals LLC.
Education includes an undergraduate degree from the University of Missouri and an MBA from the University of Phoenix.

Aktive Positionen von Michael T. Redman

UnternehmenPositionBeginn
Vorstandsvorsitzender -

Ehemalige bekannte Positionen von Michael T. Redman

UnternehmenPositionEnde
GENPREX, INC. Geschäftsführer 15.10.2021
ONCOLIX, INC. Vorstandsvorsitzender -
Vorstandsvorsitzender 01.01.2005
Corporate Officer/Principal -
Vorstandsvorsitzender -
Sehen Sie sich die Erfahrung von Michael T. Redman im Detail an

Ausbildung von Michael T. Redman

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Beziehungen

8

Beziehungen ersten Grades

14

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Unternehmensverbindungen

Private Unternehmen14

Health Technology

Health Technology

Health Technology

Commercial Services

Health Technology

Health Technology

Consumer Services

Health Technology

Consumer Services

Commercial Services

Health Technology

Health Technology

Health Technology

Health Technology

  1. Börse
  2. Insiders
  3. Michael T. Redman